CTLA4 and neoplasm: Albeit these limitations, and although tumor volumes were similar in the control and anti-PD-1/anti-CTLA-4 alone groups and only slightly reduced following treatment with TTFields alone, tumor volume was significantly lower in the group treated with concurrent TTFields and anti-PD-1/anti-CTLA-4 relative to all other groups (Figure 2B).